Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer

SLAS DISCOVERY(2023)10.1016/j.slasd.2023.08.001Source: DataRank Database

Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer is a research paper published in SLAS DISCOVERY (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.85)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Yun Hua ORCID,David A. Close ORCID,Wei Xu ORCID,Lee A. McDermott,Christopher J. Strock

Live enrichment

PubMed:37549772 PMC:PMC12366525 OpenAlex:https://openalex.org/W4385614843

National Institute of Neurological Disorders and Stroke

Grant: R01CA160423

National Institute of Neurological Disorders and Stroke

Grant: R01CA183882

University of Pittsburgh

Grant: R21NS073889

National Institutes of Health

National Cancer Institute

FWCI

0.85

Citation Percentile

0.8%

Citation Trend

2023

2025

2026

goldLicense: cc-by

journalhttp://slas-discovery.org/article/S2472555223000539/pdf

publisherhttp://slas-discovery.org/article/S2472555223000539/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2472555223000539?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555223000539?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.slasd.2023.08.001

Fields of Study

Estrogen and related hormone effectsProstate Cancer Treatment and ResearchReceptor Mechanisms and Signaling

MeSH Terms

Allosteric RegulationAntineoplastic AgentsHumansMaleProtein BindingReceptors, AndrogenTranscriptional ActivationCell Line, TumorCell ProliferationNuclear Receptor Coactivator 2Nuclear Receptor Coactivator 1Prostatic Neoplasms, Castration-Resistant

Keywords

CoactivatorAllosteric regulationAndrogen receptorProstate cancerChemistryTransactivationCancer researchPharmacologyReceptorBiologyInternal medicineBiochemistryCancerTranscription factorMedicine

Sustainable Development Goals

SDG 0: Good health and well-being

Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)